Diclofenac Sodium Tablet, Delayed Release
Product Images NDC 68071-4934

2 FDA label images from Nucare Pharmaceuticals,inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Diclofenac Sodium (NDC 68071-4934). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 4934 4)

Pdp (68071 4934 4)
Label for Diclofenac Sodium Delayed Release 75 mg tablets by NuCare Pharmaceuticals, Inc. The label indicates oral tablets, with #14 count. Features include delayed-release round white/off-white tablets imprinted with "CTI 103." Includes storage guidance and a warning to keep out of reach of children. Multiple barcodes and lot/serial details are present.*
FDA Label Image

Figure (Dic05 0006 01)

Figure (Dic05 0006 01)
Chemical structure of diclofenac sodium showing two chlorinated phenyl rings connected by an amine group and a carboxylate group attached to one ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.